zm 241385 has been researched along with sch 442416 in 8 studies
Studies (zm 241385) | Trials (zm 241385) | Recent Studies (post-2010) (zm 241385) | Studies (sch 442416) | Trials (sch 442416) | Recent Studies (post-2010) (sch 442416) |
---|---|---|---|---|---|
401 | 3 | 124 | 40 | 1 | 25 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 6 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gao, ZG; Jacobson, KA | 1 |
Cacciari, B; Cheong, SL; Federico, S; Gao, ZG; Jacobson, KA; Klotz, KN; Moro, S; Paoletta, S; Pastorin, G; Siegel, J; Spalluto, G; Stragliotto, S | 1 |
Federico, S; Jacobson, KA; Jayasekara, PS; Kozma, E; Moro, S; Paoletta, S; Spalluto, G; Squarcialupi, L | 1 |
Cacciari, B; Ciancetta, A; Federico, S; Klotz, KN; Moro, S; Pastorin, G; Porta, N; Redenti, S; Spalluto, G | 1 |
French, SW; Khachatoorian, R; Micewicz, ED; Ruchala, P | 1 |
Cipriani, S; Galli, A; Gianfriddo, M; Giovannini, MG; Mello, T; Pedata, F; Pugliese, AM; Traini, C | 1 |
Pao, AC; Rajagopal, M | 1 |
Dimitrieva, TV; Pliyev, BK; Savchenko, VG | 1 |
2 review(s) available for zm 241385 and sch 442416
Article | Year |
---|---|
Adenosine receptors as therapeutic targets.
Topics: Animals; Disease; Drug Therapy; Humans; Ligands; Molecular Structure; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Signal Transduction; Structure-Activity Relationship | 2006 |
Fluorescent ligands for adenosine receptors.
Topics: Boron Compounds; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Ligands; Protein Binding; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1 | 2013 |
6 other study(ies) available for zm 241385 and sch 442416
Article | Year |
---|---|
Synthesis and biological evaluation of a new series of 1,2,4-triazolo[1,5-a]-1,3,5-triazines as human A(2A) adenosine receptor antagonists with improved water solubility.
Topics: Adenosine A2 Receptor Antagonists; Animals; CHO Cells; Cricetinae; Cricetulus; Crystallography, X-Ray; HEK293 Cells; Humans; Hydrophobic and Hydrophilic Interactions; Models, Molecular; Protein Binding; Protein Conformation; Radioligand Assay; Solubility; Static Electricity; Structure-Activity Relationship; Triazines; Triazoles; Water | 2011 |
Scaffold decoration at positions 5 and 8 of 1,2,4-triazolo[1,5-c]pyrimidines to explore the antagonist profiling on adenosine receptors: a preliminary structure-activity relationship study.
Topics: Dose-Response Relationship, Drug; Humans; Models, Molecular; Molecular Structure; Purinergic P1 Receptor Antagonists; Pyrimidines; Receptor, Adenosine A2A; Receptor, Adenosine A3; Structure-Activity Relationship; Triazoles | 2014 |
Identification of novel small-molecule inhibitors of Zika virus infection.
Topics: A549 Cells; Antiviral Agents; Cell Survival; Dose-Response Relationship, Drug; Humans; Molecular Structure; Small Molecule Libraries; Structure-Activity Relationship; Zika Virus; Zika Virus Infection | 2018 |
The adenosine A2A receptor antagonist ZM241385 enhances neuronal survival after oxygen-glucose deprivation in rat CA1 hippocampal slices.
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; Astrocytes; Blotting, Western; Brain Ischemia; Cell Hypoxia; Cell Survival; Coloring Agents; Excitatory Postsynaptic Potentials; Glial Fibrillary Acidic Protein; Glucose; Hippocampus; Immunohistochemistry; In Vitro Techniques; Male; Neurons; Neuroprotective Agents; Oxygen; Phenethylamines; Propidium; Pyrazoles; Pyrimidines; Rats; Rats, Wistar; Receptor, Adenosine A2A; Staining and Labeling; Time Factors; Triazines; Triazoles | 2009 |
Adenosine activates a2b receptors and enhances chloride secretion in kidney inner medullary collecting duct cells.
Topics: Adenosine; Animals; Cell Line; Chlorides; Cystic Fibrosis Transmembrane Conductance Regulator; Kidney Medulla; Kidney Tubules, Collecting; Pyrazoles; Pyrimidines; Rats; Receptor, Adenosine A2B; Triazines; Triazoles; Xanthines | 2010 |
Diadenosine diphosphate (Ap₂A) delays neutrophil apoptosis via the adenosine A2A receptor and cAMP/PKA pathway.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenosine A2 Receptor Antagonists; Apoptosis; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dideoxyadenosine; Dinucleoside Phosphates; Humans; Neutrophils; Pyrazoles; Pyrimidines; Receptor, Adenosine A2A; Thionucleotides; Triazines; Triazoles | 2014 |